Related Experiment Videos
Orally administered gallbladder therapeutic agents, Part 1: Chenix (chenodeoxycholic acid, CDCA)
Summary
Chenix dissolves cholesterol gallstones by reducing bile cholesterol. This oral medication is an alternative for patients at high risk for gallstone surgery.
Area of Science:
- Hepatology and Gastroenterology
- Pharmacology
Background:
- Gallstones are a common ailment, with cholesterol stones being the most prevalent type.
- Surgical intervention, while effective, carries risks, especially for certain patient populations.
Purpose of the Study:
- To evaluate Chenix as an oral therapeutic agent for cholesterol gallstone dissolution.
- To investigate Chenix's mechanism in reducing biliary cholesterol.
Main Methods:
- Chenix administration as an oral gallstone solubilizer.
- Analysis of changes in biliary cholesterol concentration.
- Assessment of gallstone dissolution in patients at high surgical risk.
Main Results:
- Chenix effectively reduces cholesterol within the bile acid pool.
- This reduction facilitates the dissolution of floating, radiolucent cholesterol gallstones.
- Chenix offers a non-surgical treatment option for select patients.
Conclusions:
- Chenix is a viable oral treatment for cholesterol gallstones.
- It provides an alternative to surgery for patients with elevated surgical risks.